1. PharmEvo
Our Dream A Healthier Society
PharmEvo (Private) Limited, 402, Business Avenue, Block-6, P.E.C.H.S., Shahrah-e-Faisal,
Post Box 3156, Karachi-75400 PAKISTAN.
Tele. (+92-21) 3431 5195-7, 3455 6330, Fax: (+92-21) 3455 6344
2. DEMOGRAPHY
Total Area : 803,940 SQ. KM
Provinces : 5
Cities : 105
Population : 181 MILLION
Male : 51%
Female : 49%
Population Growth : 2.03 % P.A.
Life Expectancy
Male : 64 YEARS
Female : 66 YEARS
Population Distribution
Rural : 64%
Urban : 36%
Per Capita Income : $ 1,372 P.A.
5. Pakistan’s Healthcare Data
Ref- MOH and Economic Survey of Pakistan.
Major Hospitals : Nos. 965
Teaching Hospitals : Nos. 64
Dispensaries : Nos. 4,916
Basic Health Units : Nos. 5,349
Maternity Homes : Nos. 1,138
Medical Colleges : Nos. 68
Diabetic Care Centers : Nos. 200 approx.
No. of Beds : 109,005
Ratio to Population : 1 :1,575
Registered Doctors : Nos. 137,956
Ratio to Population : 1 : 1,206
No. of Dentists : 9,462
Ratio to Population : 1 : 16,426
No. of Nurses : 68,387
Ratio to Population : 1 : 3,664
No. of Nursing Schools : 14
Crude Birth Rate : 24.3 / 1,000
Crude Death Rate : 6.8 / 1,000
6. Pakistan’s Pharma Market Data.
Ref: 2012 - IMS Health Pakistan ( PKPI)
Total No. Of Companies
811
MNC 23 National
Pharma
788
Rs. 175 B
US $1.9B
Total Pharmaceutical Market
G.R 18%
Drug Price are officially controlled, Prices seized since 2000.
7. Pakistan’s Pharma Market Data.
Ref: 2012 - IMS Health Pakistan ( PKPI)
Market Share Value Wise
National
ompanies 55% MNC's 45% Market Share Unit Wise
National
Companies 49% MNC, 51%
8. Premier Group of Companies
Premier Distributors
Premier Agencies
PharmEvo
Zaman Textiles
Shield Corporation
9. Growth History - Group
US$ 50 million in 2005 to US$ 210 Million in 2011
US$ 210 Million
US$ 50 million
(15% growth comes from existing account & rest from new accounts)
10. GROUP’s INVESTMENT
– English Biscuits Mfg: Largest Biscuit / confectionary company in
Pakistan, Group has 20% shareholding.
– National Foods Ltd.: Largest package food company in Pakistan, 5%
shareholding.
–
– Mr. Ebrahim Qassim is the board member of both the companies.
– Mr. Haroon Qassim is the board member of English Biscuits Mfg.
11. PREMIER GROUP
Committed Partnership
– English Biscuits – PF (in 1987 equity participation) 1971 37 years
– National Foods (in 1995 equity participation) 1973 35 years
– Sanofi Aventis 1975 33 years
– Mitchells 1979 29 years
– Shield Corporation Limited 1979 29 years
– Unilever Pakistan - Rafhan Best Foods (1980 to 2008) 28 years
– Searle (1973 to 1998) 26 years
– Becton Dickinson 1989 19 years
– Toyo Nasic 1993 15 years
– Cadbury Pakistan 1989 19 years
– Abbott Nutrition International 2000 08 years
14. Zaman Textiles
Started its operation in 1985
Acquired by the group in 2003
Leading manufacturers of export quality 100% cotton yarn
Export regions include Asia, Africa, and South America
Aggressive expansion plans in progress, planned for the next 3 years
15. Shield Corporation
Started its operations in 1984
Over 30% market share in baby care products (feeders,
soothers, nipples, and teethers) within the local market
Did Contract manufacturing for Gillette Pakistan
for their Oral B and Contra lines of brushes until P&G took over.
18. Diagnostics(Omron)
• OMRON Corporation based in Japan since 1933, with a presence nearly all regions
of the world.
Product Lineup
Blood Pressure Monitors
Digital Thermometers
Body Composition Monitors
Pedometers
Nebulizer
Others
19. Nutrition(Celia)
• Lactalis Worlds Largest Dairy / Nutritional based in France, with a
presence nearly 150 countries.
21. Vision
VISION
“Our dream is to build a healthier society
by becoming a leading and socially
responsible global company through
innovative solutions”
22. Mission
MISSION
• Our mission is to be a global organization whose philosophy is characterized by a
highly refined sense of ethics which is expressed tangibly through its dealings
while upholding highest standards of integrity.
• An organization that aspires to be a leader in providing quality healthcare
solutions and where patients’ wellbeing is viewed as the ultimate concern.
• Creates differentiation through pioneer ship in Cause Oriented Marketing.
– Cares for its employees, recognizes merit through rewards on achievements.
– Bears a progressive approach thereby encouraging initiatives, welcoming
new ideas and always ready to move off the beaten track.
– Respects the hands that help relief pain and suffering.
– Embraces Information Technology as heart of the business and employs
leading technologies to help achieve defined objectives.
• Seeks to assure fair returns on investments through sustainability and growth
23. PharmEvo Private Limited
“ More than1,000 people are working at
People PharmEvo
to help save lives and
improve quality of life ”
“17 Million USD
Revenue
in just 10 years.”
“Marketing more than
Products 112 variations
Of Pharmaceutical preparations”
24. PharmEvo Private Limited
“PharmEvo is the
1st Pharmaceutical Company in Pakistan
System to have a complete BMS
OTHERS: Integrated Management Systems
”
(ISO 9000, ISO 14000 & ISO 18000)
“8 International Partners ”
“PharmEvo achieves
Partnership success through close cooperation
with partners who share a common
vision and complementary strengths. ”
25. Our Partners
Beijing Kawin Technology Share-Holding Co., Ltd PRC
Becton Dickinson USA
POLAND
FRANCE
KOREA
PRC
JAPAN
Nanjing Aosaikang Medicinal Group, PRC
26. PharmEvo Private Limited
“ Currently we operate in
Location 9 Countries,
with our headquarter in Karachi, Pakistan ”
Kenya
Sri Lanka Myanmar Vietnam
Afghanistan Cambodia Guatemala Philippines
27. PharmEvo Private Limited
Export Focus:
International Far East, Middle East & Africa,
CIS, South America, EU Countries
Operations
Markets under Development
Malaysia Yemen
Uzbekistan
Tanzania Kazakhstan
27
28. PharmEvo Private Limited
“HR”
Total group employees around 3,513
“DISTRIBUTION NETWORK”
Our Strengths 2,000 SKU’s, 500 vans,
14,00 Sales Personnel's,
8 visits a week to 25,000 – 30,000 pharmacies
“TURNOVER”
Group’s turnover is over
Rs.18 Billion (US $210 Million)
28
29. PharmEvo Private Limited
“QUALITY”
PharmEvo’s Success Story Starts from
Quality Product, Which is maintained through
our high professionals in Production
“RESEARCH”
Our Strengths One of the hallmarks of PharmEvo’s success is
providing local clinical data to the medical
community through Clinision Department
“MARKETING”
Has Positioned our company as an organization
that goes beyond physical healthcare
And has Established brands and Corporate image
29
30. PharmEvo Private Limited
“BUSINESS DEVELOPMENT
&
Our Strengths LICENSING”
Through
Strategic Alliances, Portfolio Management
& Developing New Markets
30
31. Total PharmEvo Brand Sales from 2000 – 2011,
2012 Target (Rs.2,000 Million) = USD 24 Million
(Pakistan Operations)
33. 3rd Qtr 2011
Total & PHARMEVO Sales trend over last 5 years
MKT PHARMEVO
Rs. Mn
180,000
CAGR 11 Vs 07
161,358
160,000 TOTAL MKT. 15.89%
NATIONAL 18.05%
140,000 135,013
PHARMEVO 27.72%
118,855
120,000
Millions
Millions
100,059
100,000 1,327
89,449
1,041 90,198
80,000
73,587
60,000
885
64,697
672 53,449
40,000 46,510
499
20,000
0
2007 2008 2009 2010 2011
Total NATIONAL PHARMEVO
• PHARMEVO has an upward Sales in 3Q 2011, CAGR is 27.72% which is higher than Total Market and
Nationals
34. 3rd Qtr 2011
Total & PHARMEVO Growth trend over last 4 years
%
40.00
34.80
31.61
30.00
27.49
22.57
21.04
20.00
17.65
14.92 18.79 19.51
13.74
13.59
10.00
11.86
0.00
2008 2009 2010 2011
Years
Total NATIONAL PHARMEVO
• PHARMEVO has shown better growth in 3Q 2011 as compared to same period last year
35. 3rd Qtr 2011
Total & PHARMEVO Unit Growth trend over last 4 years
%
30.00
25.77
23.85
20.00
15.28
12.88 14.32
8.01
10.00 6.45
7.74 10.94 10.78
6.27 5.95
0.00
2008 2009 2010 2011
Years
Total NATIONAL PHARMEVO
• PHARMEVO has shown better growth in 3Q 2011 as compared to same period last year
39. At PharmEvo we have infrastructure and expertise to conduct
PHASE-II - IV – clinical studies
At present we are highly engaged / involved in Phase IV clinical trials
One of the hallmarks of PharmEvo’s success is providing
local clinical data to the medical community
Up till now we have conducted clinical trials on local population in
Cardiovascular, Diabetes, Analgesic & Anti-Infective segments
40. Marketing Strategies
Medical Involvement
Aggressive Promotion
Skilled Sales Force
Achieve
Customer Satisfaction
41. Marketing Philosophy / Activities
Unique Books publication and distribution Thematic calendars since 2000
Sponsoring Digital libraries in large hospitals and medical schools
Rewards and Incentives to Medical Students Local User Trials
Video Shows Skill development opportunities for medical professionals
Career guidance workshops for young students
42. Statistical and Training Services Provided by Clinision
Total 245 Statistical services requests completed
43. Research Data Compiling Training Services Provided to Doctors by Clinision- A
PharmEvo’s Division
Total Doctors
Trained so Far
1,932
48. Distribution Network
Manufacturer
National Distributor/
Preferred Dealers Wholesaler Retailer
Company's Own distribution
Dispensing Govt./Pvt.
Doctors Hospitals/Clinics
Consumer
Cytotoxic drugs
Normal
49. Manufacturing Facility Overview
10 Acre Facility, Michael Taylor Consultant
Modernized Manufacturing Facility As Per GMP & FDA Requirements
IMS accreditation (ISO 9001:2000-QMS), (ISO 14001:2004-EMS) &
(ISO 18001:2000_OHSAS).
Completely Separate Buildings For Cephalosporin &
Non-Cephalosporin Products As Per WHO Guidelines
52. Main Features
Dedicated building for the formulation of Cephalosporin
21 Air handling units installed in operational areas
Building Management System ( BMS) from Honeywell
53. Production Area – Main Building
Non-Sensitive Pharmaceuticals
Sections
Capsule Section
Tablet Section
Oral liquid Section
Ointment Section
Warehouse
Packaging
Quality Assurance
Total Production area - 16,000 Sq. Ft.
54. Production Area Cephalosporin's
Sections
Capsule Section
Tablet Section
Dry Powder Suspension
Components washing & sterilization
Sterile Injection Section
Packaging Section
Material Handling Section
Total Production area – 9,000 Sq. Ft.
55. Quality Assurance
No Compromise On Quality –
ZERO TOLERANCE POLICY
Fully Equipped Laboratory
Latest Equipment's For
Complete Analysis Of Products
56. Building Management System -BMS
PharmEvo is the first pharmaceutical
company in Pakistan to have a
complete BMS.
57. Salient features - BMS
Online Monitoring & Control Of
Manufacturing room parameters
Air Flow & Volume
Relative Humidity
Air Handling Units
Air Filtration System
HEPA Filter Performance For GMP Compliance
Manufacturing As Per Pharmacopeial Specifications.
64. DIRECTOR
MARKETING
Organogram DIRECTOR
BUSINESS
MARKETING
MANAGER-1
DEVELOPMENT
DIRECTOR
MARKETING
TECHNICAL
MANAGER-2
OPERATIONS
BUSINESS
UNIT MANAGER -1
DIRECTOR
MARKETING
INTERNATIONAL
MANAGER-3
MARKETING
BUSINESS
UNIT MANAGER -2
MANAGING DIRECTOR MARKETING
CHAIRMAN
DIRECTOR FINANCE MANAGER-4
BUSINESS
UNIT MANAGER -3
DIRECTOR
MARKETING
MEDICAL
MANAGER-5
AFFAIRS
BUSINESS
UNIT MANAGER -4
GENERAL MANAGER
HUMAN
RESOURCES
BOARD OF DIRECTORS:
Ebrahim Qassim Group Chairman
Derek Evans Chairman PharmEvo MANAGER
M. Haroon Qassim Managing Director MIS
Zamiruddin Ahmed Director
MANAGER
INTERNAL
AUDIT
65. Key Personnel
Ebrahim Qassim (Group Chairman)
Chartered Accountant
40 years of experience ranging from Pharmaceuticals, Distribution, and Textiles to
Consumer Goods
Served on many professional organizations, including KSE, ICAP, MAP, etc.
A renowned and respected industrialist
Derek Alan Evans (Chairman PharmEvo)
Derek joined Searle in 1963 and served until 1987 when he retired as Vice President
for Searle operation in Europe.
Appointment in National Health Service (NHS) of the West London Health Authority
in 1998.
Chairman of Stoke Mandeville Hospital which is the largest paraplegic hospital in
Europe from which he retired in 2005
66. Key Personnel (Continued..)
M. Haroon Qassim (Managing Director)
CPA and MBA (USA)
17 years of experience ranging from Distribution & Finance to Pharmaceuticals.
Ex-Chairman Pakistan Pharmaceutical Manufacturers Association. ( PPMA )
Dr. Munir Anwar (Director Technical )
MBA, PhD in Pharmacognosy from University of Karachi
32 years experience in Pharmaceutical Manufacturing
67. Key Personnel (Continued..)
S. Jamshed Ahmad (Director Marketing& Sales)
B. Pharm, MBA Pharmaceutical Marketing USA.
17 Years Experience in Pharmaceutical Marketing
M. Nadeem Rehmat (Director Business Development)
B.Pharm, MBA
Over 17 years of experience in Pharmaceutical Industry / Business
Development
68. What Pakistan Offers?
A Positive Shift In Perception Of Doctors Towards National Companies
High-Quality Human Resources
Auxiliary Industries Established
Easy Access To CIS (Central independent State)
69. What PharmEvo Offers?
Expertise In
700+ Most Credible
Medical Reps
Corporate Image Top 8
In Pakistan Therapeutic Categories
Business Ethics Aggressive
& &
Ensured
Knowledge
Based Philosophy
Responsive
Culture
Quality
70. What Are We Looking For?
Customer
Satisfaction
Marketing
Collaboration
Manufacturing JV’s
B.D & Licensing
Strategic Alliances
